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Purpose The prognosis of dizzy older patients in primary care is unknown. Our objective 
was to determine the prognosis and survival of patients with different subtypes and 
causes of dizziness.    
Methods In a primary care prospective cohort study, 417 older adults with dizziness 
(mean age 75.5 years) received a full diagnostic workup in 2006-2008. A panel of 
physicians classified their dizziness subtype and primary cause of dizziness. Presyncope 
was the most common dizziness subtype (69.1%), followed by vertigo (41.0%), 
disequilibrium (39.8%), and other dizziness (1.7%). The most common primary causes of 
dizziness were cardiovascular disease (56.8%) and peripheral vestibular disease (14.4%). 
Main outcome measures were mortality and dizziness-related impairment assessed at 10-
year follow-up. 
Results At 10-year follow-up 169 patients (40.5%) had died. Multivariable adjusted Cox 
models showed a lower mortality rate for patients with the subtype vertigo compared to 
other subtypes (HR 0.62 (95% CI 0.40 to 0.96)), and for peripheral vestibular disease 
versus cardiovascular disease as primary cause of dizziness (HR 0.46 (95% CI 0.25 to 
0.84)). After 10 years, 47.7% of patients who filled out the follow-up measurement 
experienced substantial dizziness-related impairment. No significant difference in 
substantial impairment was seen between different subtypes and primary causes of 
dizziness.  
Conclusions The 10-year mortality rate was lower for the dizziness subtype vertigo 
compared to other subtypes. Patients with dizziness primarily caused by peripheral 
vestibular disease had a lower mortality rate than patients with cardiovascular disease. 
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Substantial dizziness-related impairment in older dizzy patients 10 years later is high, and 




Dizziness is a common problem among older patients in primary care (1). The annual 
prevalence of dizziness in adults ranges between 20-30% in population-based 
questionnaire studies (2). The frequency and severity of dizziness symptoms generally 
increase with age (3). Diagnosing dizziness and estimating its prognosis is a complex 
problem for clinicians (4). Dizziness is a subjective sensation, only measurable by self-
report, that can be caused by a broad array of benign but also by serious medical 
conditions. The diagnostic process is particularly challenging in dizzy older patients, 
because the cause of their dizziness is mostly multifactorial (5, 6). Dizziness is often 
divided in four major subtypes: vertigo, presyncope (also known as light-headedness), 
disequilibrium (also known as unsteadiness) and other dizziness (7-9). Different subtypes 
are generally associated with different organ systems such as peripheral vestibular 
disease or cardiovascular disease (4, 5). Determining the cause of dizziness might help in 
choosing an appropriate treatment. 
 
Over 80% of patients experiencing dizziness in The Netherlands, UK and USA are 
primarily treated by their primary care physician and are never referred to a specialist 
(10-12). Nevertheless, most diagnostic and prognostic studies investigated patients in 
secondary and tertiary care settings (13-15). We started a prospective cohort study in 
2006 to gain more insight in the diagnosis and prognosis of older dizzy patients in 
primary care (5). This study already yielded new insights into diagnosing dizziness in 
primary care that have been reported in previous publications (5, 16, 17). By following 
these patients over a 10-year period we are now also able to investigate the long-term 
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prognosis of older dizzy patients in primary care. Dizziness has been associated with 
increased premature mortality (18) and substantial functional impairment (16, 19), but it 
is unclear if these risks are equal for all subtypes and causes of dizziness. More specific 
prognostic information may help family physicians to timely identify and treat high-risk 
patients. The objective of this study is to investigate if and how the dizziness subtypes 
and primary causes of dizziness are associated with mortality and dizziness-related 
impairment 10 years later.    
 
Methods 
Participants and baseline assessments 
The details of the inclusion and baseline data collection of the Dizziness In Elderly 
Patients (DIEP) cohort were reported previously (5, 20). In summary, we prospectively 
identified 417 older primary care patients (aged ≥65 years) with dizziness that had been 
present for at least two weeks from June 2006 to January 2008. An international Delphi 
procedure was used to determine a comprehensive list of useful diagnostic dizziness tests. 
At inclusion all patients received this full diagnostic workup. We recorded 
sociodemographic characteristics, smoking habits, alcohol intake, current use of 
medication, medical history, characteristics of dizziness, and the use of a hearing, seeing, 
or walking aid. All patients had to complete the Primary Care Evaluation of Mental 
Disorders (PRIME-MD) Patient Health Questionnaire (PHQ), a self-administered 
instrument to assess psychiatric disorders (21, 22). During the physical examination we 
assessed the following organ systems: cardiovascular (pulse, blood pressure, orthostatic 
hypotension measurement), locomotor (orthopaedic screening of lower limbs, tandem 
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gait, timed up-and-go test), neurological (tendon reflexes, Semmes-Weinstein 
monofilament test), vestibular (otoscopy, Dix-Hallpike manoeuvre, audiometry) and 
visual (Landolt rings eye chart). We also tested haemoglobin and non-fasting blood 
glucose levels in the laboratory and performed an electrocardiogram and continuous 
event recording on indication. Next, a panel consisting of a family physician, a 
geriatrician and a nursing home physician independently reviewed the data for each 
patient to ascertain dizziness subtype and (major and minor contributory) causes of 
dizziness. Every participant was definitively categorized into one or more of the four 
dizziness subtypes by means of a majority decision (at least two of three panel members 
had to agree). In addition, the panel classified the relative contribution (from 0% to 
100%) of causes of dizziness for each patient from a list of nine possible groups of 
medical conditions: cardiovascular disease (including cerebrovascular disease), 
peripheral vestibular disease, psychiatric disease, locomotor disease, neurological disease 
(excluding cerebrovascular disease), adverse drug effect, metabolic or endocrine 
conditions, impaired vision and other cause. All causes that were scored higher than 0% 
by at least two out of three panel members were considered as a contributory cause. The 
medical condition with the highest mean contributing percentage across all three 
reviewers was identified as the primary cause of dizziness (5).  
 
Follow-up 
Our primary outcomes are mortality and significant impairment due to dizziness. The 
follow-up measurements took place between October 2016 and January 2018, 
approximately 10 years after the start of the study. Deaths were identified through FP 
 
 7 
records and reports by next of kin. Patients lost to follow-up were censored at the last day 
confirmed to be alive. When the exact day of death was unclear, we entered the middle of 
the known month or year as date of death. We used the Dizziness Handicap Inventory 
(DHI) to assess impairment due to dizziness (23). The DHI is the most widely used 
questionnaire for dizziness and can be used to quantify self-perceived impact of dizziness 
on daily life (24). It has been shown to have good construct validity, high internal 
consistency, and satisfactory test-retest reliability (23, 25-27). The questionnaire consists 
of 25 questions (score range 0-100); higher scores correspond with more handicapping 
effects due to dizziness. A total DHI-score of 30 or higher is generally believed to 
indicate substantial dizziness-related impairment (25, 28, 29). Participants were asked to 
fill out a DHI questionnaire at baseline, and after six months (30) and 10 year follow-up. 
Participants who were mentally or physically unable to complete a questionnaire were 
excluded.     
 
Statistical analyses 
To analyse the relationship between dizziness and mortality, first we calculated the time 
to event from the date of enrolment in the DIEP cohort to date of death or the end of 
follow-up, whichever came first. Second, we generated Kaplan Meier survival curves for 
the four dizziness subtypes and compared them with log rank tests. Third, we performed 
Cox proportional hazard models to estimate hazard ratios with 95% confidence intervals 
for the four different dizziness subtypes and for the nine primary causes. Based on 
previous studies and feasibility, we pre-specified the following potential confounders: 
age (18, 31-33), sex (18, 31-33), ethnicity (18, 31), level of education (18, 31), pre-
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existent cardiovascular disease (18, 32), pre-existent stroke (18, 32), pre-existent diabetes 
(18, 30), polypharmacy (defined as >5 types of daily medication) (30, 32, 34), a 
comorbid anxiety or depressive disorder at baseline according to the PRIME-MD PHQ 
(30-32, 35) and the number of assigned dizziness subtypes. The ten potential confounders 
are described in more detail in Supplementary Appendix 1. We adjusted for these pre-
specified potential confounders by adding them as covariates to the models. To analyse 
the relationship with dizziness-related impairment, we used total DHI-scores at baseline, 
six-month follow-up and 10-year follow-up as outcome. These scores were analysed both 
as a continuous variable and a dichotomous variable (i.e. no substantial impairment [DHI 
scores between 0 and 29] and substantial impairment [DHI scores between 30 and 100]). 
For the continuous outcome we used linear mixed model analysis, and for dichotomous 
outcome we used logistic generalized estimating equations (GEE analysis) (36). Both 
methods take into account the dependency of the observations within the patient. In both 
analyses, we adjusted for the same pre-specified potential confounders as for the Cox 
proportional hazard models. We also conducted one exploratory analysis and two post 
hoc sensitivity analyses to test the robustness of our findings. In the exploratory analysis, 
we graphically illustrated how participants who filled out the 10-year DHI measurement 
tracked over all three time points. In the first sensitivity analysis, the dizziness subtype in 
patients had to be agreed upon by all three panel physicians (unanimous decision) instead 
of at least two out of three panel physicians (majority decision). In the second sensitivity 
analysis, only participants who were assigned to one subtype were included in the 






The DIEP cohort consists of 417 participants. At baseline, the mean age of participants 
was 78.5 years (range 65-95); 74% were female and 69% had experienced dizziness for 
more than six months. Presyncope was the most common dizziness subtype (69.1%), 
followed by vertigo (41.1%), disequilibrium (39.8%), and other dizziness (1.7%). 
Patients were assigned by the panel to one subtype (52.0%), two subtypes (32.9%), three 
subtypes (11.3%) or no subtype at all (3.8%). According to the panel, the most common 
primary causes of dizziness were cardiovascular disease (56.8%), and peripheral 
vestibular disease (14.4%). The baseline characteristics are presented in Table 1. After 10 
years, 103 participants (24.7%) filled out a DHI and could be analysed for dizziness-
related impairment. Of the other participants 169 (40.5%) had died, 86 (20.6%) had no 
known address or did not respond to the questionnaire, 30 (7.2%) suffered from serious 
cognitive disorders, 21 (5.0%) were contacted but refused to participate and 8 (1,9%) had 




At 10-year follow-up 169 deaths were recorded (40.5%). The association between 
mortality and dizziness subtypes is shown in Table 2, before and after adjusting for 
potential confounders. Participants with the subtype vertigo had a lower 10-year mortality 
risk (hazard ratio 0.62, 95% confidence interval 0.40 to 0.96) than participants with other 
dizziness subtypes. The Kaplan-Meier survival curve in Figure 1 further illustrates this 
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association. Table 3 and Figure 2 show the association between mortality and the primary 
cause of dizziness, again before and after adjusting for potential confounders. Dizziness 
due to peripheral vestibular disease was associated with a lower hazard of death (hazard 




An overview of DHI-scores for each measurement moment is presented in Table 4. At 
baseline, the mean DHI-score was 36.3 and 60.7% of participants had a DHI-score ≥ 30 
which constitutes substantial impairment due to dizziness. After 10 years, the average 
DHI-score was 31.1 and 47.4% of the 103 participants still experienced substantial 
dizziness-related impairment. Approximately one third (34%) of these participants never 
reported substantial dizziness-related impairment, while one fourth (26%) experienced 
this at every measurement.  
 
Table 5 shows the association between dizziness subtypes and dizziness-related 
impairment 10 years later. The dizziness subtype presyncope was associated with a lower 
mean DHI-score than in participants without this subtype, but not with a significant lower 
odds at substantial dizziness-related impairment. Other subtypes were not significantly 
associated with DHI-scores, nor were the different primary causes of dizziness such as 
vascular or peripheral vestibular disease. The relationship between these primary causes 




Exploratory and sensitivity analyses 
In Supplementary Appendix 2, we listed the baseline characteristics of patients who were 
still alive and had died during follow-up. Compared to deceased patients, patients who 
were alive at follow-up were younger, more often female and used more medication. In 
Supplementary Appendix 3, we listed the baseline characteristics of alive patients at 
follow-up who filled out the 10-year DHI measurement versus patients who did not. In an 
exploratory analysis, we used the DHI total score of each of the 103 participants at the 
baseline, six month and 10-year measurement to analyse how scores tracked over time. 
As graphically shown in Supplementary Figure 1, no clear pattern can be identified in 
these scores.  
 
In the first sensitivity analysis, the dizziness subtype in patients had to be agreed upon by 
all three panel physicians (unanimous decision) instead of at least two out of three panel 
physicians (majority decision). Supplementary Tables 1 and 2 show the association of 
unanimous dizziness subtypes with mortality and dizziness-related impairment 10 years 
later. The associations of unanimous subtypes with mortality were comparable to the 
main analysis, but failed to reach statistical significance due to larger confidence 
intervals. Unlike the majority decision subtype presyncope , the unanimous subtype 
presyncope was not associated with DHI-score. In the second sensitivity analysis, only 
participants who were assigned to one subtype (N=217) were included in the analyses. 
Supplementary Tables 3 and 4 show the associations between dizziness subtypes with 
mortality and dizziness-related impairment 10 years later in this group of patients. The 
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associations are similar to the main analysis, but due to the small number of patients in 






In a prospective 10-year cohort study in primary care with older patients with panel-
diagnosed dizziness, we analysed the association of different subtypes and primary 
causes of dizziness with mortality and dizziness-related impairment. The dizziness 
subtype vertigo was associated with a lower mortality rate in the 10-year period than the 
subtypes presyncope, disequilibrium and other dizziness. Dizziness due to peripheral 
vestibular disease was associated with a lower risk of mortality in 10 years than dizziness 
due to cardiovascular disease. Although subtypes and primary causes of dizziness were 
not significantly associated with the development of substantial impairment due to 
dizziness, participants with the presyncope subtype did have relatively less dizziness 
symptoms 10 years later. A final notable finding was that even though dizziness is often 
seen as a self-limiting affliction, almost half of all participants who filled out the 10-year 
measurement felt substantially impaired due to dizziness.   
 
Comparison with existing literature 
In a large American population-based cohort study the presence of dizziness in the last 12 
months was an independent risk factor for mortality (18). After adjusting for relevant 
covariates including age, ethnicity, race, gender, diabetes, cardiovascular, 
cerebrovascular disease and cancer, being dizzy was a risk factor for early mortality 
comparable to leading causes of death such as cardiovascular disease and cancer (18). 
This is the first study that examines differences in mortality for subtypes and causes of 
dizziness. We found that the vertigo subtype and dizziness primarily due to peripheral 
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vestibular disease were associated with a lower mortality rate in a 10-year period. 
Intuitively, this might not be surprising because vertigo patients and patients with 
peripheral vestibular disease are younger on average and more often female than 
presyncope patients and patients with cardiovascular disease (5). Nevertheless, these 
associations remained significant after adjusting for age, gender and other confounders.  
Research on the prognosis of dizziness in primary care is scarce (37). Most 
epidemiological studies in community-dwelling older adults have been cross-sectional 
(2).  Only three long-term prospective cohort studies (>1 year) were identified and none 
of these studies measured dizziness-related impairment longitudinally (31-33). Our study 
found less dizziness-related impairment in presyncope patients, but not less substantial 
dizziness-related impairment (DHI≥30). This is the first prognostic longitudinal study 
that identifies a difference in dizziness-related impairment between subtypes. These 
results should be interpreted with caution though, because they might be explained by the 
higher mortality rate in the presyncope group (survivor bias (38)). No other associations 
between dizziness-related impairment and subtypes or primary causes of dizziness were 
identified. Overall, 47.7% of patients who filled out the 10-year measurement 
experienced substantial dizziness-related impairment. This suggests that current treatment 
strategies in primary care may be suboptimal.  
 
Strengths and limitations 
Our study has several strengths. An extensive diagnostic set of tests for dizziness was 
developed based on a systematic review and a Delphi procedure with experts in the field 
(20). All participants completed this workup and were then diagnosed by a panel of three 
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physicians, which is the preferred diagnostic method when a gold standard is not 
available (39). Considering this time-intensive inclusion process, we managed to include 
a sizeable cohort of 417 participants.  
There are also some limitations. First, Drachman’s categorization in four subtypes is still 
widely used, but not undisputed. There is a risk of misdiagnosis when we only focus on 
the way patients describe their dizziness, e.g. a “spinning sensation” or “light-
headedness”. At the moment, a paradigm shift in diagnosing dizziness is taking place 
which focuses less on the patients’ description of their dizziness sensation and more on 
timing and triggers (40, 41). New terminology has been proposed, but in most guidelines 
dizzy patients are still categorized according to the classical four subtypes (8, 9). Our 
panel did not base their diagnosis on the patients’ description of dizziness but on a 
comprehensive set of diagnostic tests and an extensive medical history including timing 
and triggers. Therefore, future changes in nomenclature and diagnostic procedures will 
not directly invalidate the results of our study. General practitioners will continue to have 
to assess the primary cause of dizziness and identify patients at risk for persistent 
impairment due to dizziness (28). Second, we adjusted in our analyses for ten potential 
confounders. To limit the risk of bias, covariates were defined before we conducted our 
analyses. We chose these confounders based on feasibility and a literature review of 
previous studies (18, 30-35). Although we have attempted to adjust for the most relevant 
confounders, we cannot exclude the possibility that unidentified factors influenced our 
primary outcomes. Third, due to the advanced age of our participants at inclusion, only a 
limited subset was available for analysis of dizziness-related impairment 10 years later. 
This small sample size might be why we found no significant differences between 
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different primary causes of dizziness. In the main analysis, the dizziness subtype 
presyncope, as determined by a majority decision of the panel, was associated with a 
lower mean DHI-score 10 years later. However, in a sensitivity analysis that only 
assigned patients to a subtype if all three panel members agreed, the subtype presyncope 
was not associated with the DHI-score. This indicates that the results we found on the 
association between different dizziness subtypes and long-term dizziness-related 
impairment should be interpreted with care.  
 
Conclusions and implications for research and/or practice 
These results provide new insights in the prognosis of older dizzy patients in primary 
care. The 10-year survival was higher for patients with the subtype vertigo compared to 
other subtypes. Patients with dizziness primarily caused by peripheral vestibular disease 
also lived longer than patients with dizziness caused by vascular disease. Differences in 
subtype and primary cause of dizziness were not associated with substantial dizziness-
related impairment 10 years later. The large percentage of older dizzy patients that 
experience substantial dizziness-related impairment 10 years later indicates that current 
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